SearchDictionaryMobileLogin

[A placebo-controlled, double-blind, randomized trial of single daily dose of anti-muscarinic drug solifenacin succinate in patients with overactive bladder]

AuthorsL Cardozo, M Lisec, R Milard, O Van Vierssen Trip, I Kuzmin, T E Drogendijk, A M Huang
JournalAkusherstvo i ginekologii͡a (Akush Ginekol (Sofiia)) Vol. 46 Issue 5 Pg. 55-7 ( 2007) ISSN: 0324-0959 Bulgaria
PMID17974184 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Muscarinic Antagonists
  • Quinuclidines
  • Tetrahydroisoquinolines
  • quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate
Topics
  • Adult
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Muscarinic Antagonists (administration & dosage, adverse effects, therapeutic use)
  • Quinuclidines (administration & dosage, adverse effects, therapeutic use)
  • Tetrahydroisoquinolines (administration & dosage, adverse effects, therapeutic use)
  • Treatment Outcome
  • Urinary Bladder, Overactive (drug therapy, metabolism)
  • Urination (drug effects)